CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism. / Coutinho, Ester; Jacobson, Leslie; Pedersen, Marianne Giørtz; Benros, Michael Eriksen; Nørgaard-Pedersen, Bent; Mortensen, Preben Bo; Harrison, Paul J; Vincent, Angela.

I: Journal of neurology, neurosurgery, and psychiatry, Bind 88, Nr. 9, 2017, s. 718-721.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Coutinho, E, Jacobson, L, Pedersen, MG, Benros, ME, Nørgaard-Pedersen, B, Mortensen, PB, Harrison, PJ & Vincent, A 2017, 'CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism', Journal of neurology, neurosurgery, and psychiatry, bind 88, nr. 9, s. 718-721. https://doi.org/10.1136/jnnp-2016-315251

APA

Coutinho, E., Jacobson, L., Pedersen, M. G., Benros, M. E., Nørgaard-Pedersen, B., Mortensen, P. B., Harrison, P. J., & Vincent, A. (2017). CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism. Journal of neurology, neurosurgery, and psychiatry, 88(9), 718-721. https://doi.org/10.1136/jnnp-2016-315251

Vancouver

Coutinho E, Jacobson L, Pedersen MG, Benros ME, Nørgaard-Pedersen B, Mortensen PB o.a. CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism. Journal of neurology, neurosurgery, and psychiatry. 2017;88(9):718-721. https://doi.org/10.1136/jnnp-2016-315251

Author

Coutinho, Ester ; Jacobson, Leslie ; Pedersen, Marianne Giørtz ; Benros, Michael Eriksen ; Nørgaard-Pedersen, Bent ; Mortensen, Preben Bo ; Harrison, Paul J ; Vincent, Angela. / CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism. I: Journal of neurology, neurosurgery, and psychiatry. 2017 ; Bind 88, Nr. 9. s. 718-721.

Bibtex

@article{7f842c6ccbc04775bfbcd00c70acf01a,
title = "CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism",
abstract = "BACKGROUND, METHODS AND OBJECTIVES: Maternal autoantibodies to neuronal proteins may be one cause of neurodevelopmental disorders. This exploratory study used the Danish archived midgestational sera and their nationwide registers to search for antibodies to the N-methyl-D-aspartate receptor (NMDAR) and contactin-associated protein-like 2 (CASPR2) in maternal sera, and to relate them to subsequent psychiatric diagnoses in the woman or her child.RESULTS: In a sample of 192 women, there was no association between antibody status and subsequent psychosis in the mothers. However, NMDAR antibodies (n=4) or CASPR2 antibodies (n=1) were identified in 5/11 (45.5%) women whose children were given a diagnosis of mild or unspecified mental retardation or disorders of psychological and motor development (collectively abbreviated as mental retardation and/or disorders of psychological development (MR/DPD)) compared with 9/176 (5.1%) of the remaining mother (p<0.001). These findings were followed up in a specifically selected cohort, in which CASPR2 antibodies were detected in 7/171 (4.1%) mothers of MR/DPD progeny, compared with only 1/171 (0.6%) control mother (p=0.067). The combined sample showed a significantly higher frequency of CASPR2 antibodies in mothers of MD/DPD children (p=0.01). These autoantibodies were not increased in mothers of children with autistic spectrum disorder.CONCLUSIONS: These findings complement the known roles of CASPR2 in brain development, and warrant further epidemiological and experimental studies to clarify the role of CASPR2 and possibly other antibodies in neurodevelopmental disorders.",
keywords = "Autoantibodies/immunology, Brain/immunology, Denmark, Female, Humans, Infant, Newborn, Intellectual Disability/diagnosis, Membrane Proteins/immunology, Mothers/psychology, Nerve Tissue Proteins/immunology, Pregnancy, Receptors, N-Methyl-D-Aspartate",
author = "Ester Coutinho and Leslie Jacobson and Pedersen, {Marianne Gi{\o}rtz} and Benros, {Michael Eriksen} and Bent N{\o}rgaard-Pedersen and Mortensen, {Preben Bo} and Harrison, {Paul J} and Angela Vincent",
note = "{\textcopyright} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.",
year = "2017",
doi = "10.1136/jnnp-2016-315251",
language = "English",
volume = "88",
pages = "718--721",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "B M J Group",
number = "9",

}

RIS

TY - JOUR

T1 - CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism

AU - Coutinho, Ester

AU - Jacobson, Leslie

AU - Pedersen, Marianne Giørtz

AU - Benros, Michael Eriksen

AU - Nørgaard-Pedersen, Bent

AU - Mortensen, Preben Bo

AU - Harrison, Paul J

AU - Vincent, Angela

N1 - © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

PY - 2017

Y1 - 2017

N2 - BACKGROUND, METHODS AND OBJECTIVES: Maternal autoantibodies to neuronal proteins may be one cause of neurodevelopmental disorders. This exploratory study used the Danish archived midgestational sera and their nationwide registers to search for antibodies to the N-methyl-D-aspartate receptor (NMDAR) and contactin-associated protein-like 2 (CASPR2) in maternal sera, and to relate them to subsequent psychiatric diagnoses in the woman or her child.RESULTS: In a sample of 192 women, there was no association between antibody status and subsequent psychosis in the mothers. However, NMDAR antibodies (n=4) or CASPR2 antibodies (n=1) were identified in 5/11 (45.5%) women whose children were given a diagnosis of mild or unspecified mental retardation or disorders of psychological and motor development (collectively abbreviated as mental retardation and/or disorders of psychological development (MR/DPD)) compared with 9/176 (5.1%) of the remaining mother (p<0.001). These findings were followed up in a specifically selected cohort, in which CASPR2 antibodies were detected in 7/171 (4.1%) mothers of MR/DPD progeny, compared with only 1/171 (0.6%) control mother (p=0.067). The combined sample showed a significantly higher frequency of CASPR2 antibodies in mothers of MD/DPD children (p=0.01). These autoantibodies were not increased in mothers of children with autistic spectrum disorder.CONCLUSIONS: These findings complement the known roles of CASPR2 in brain development, and warrant further epidemiological and experimental studies to clarify the role of CASPR2 and possibly other antibodies in neurodevelopmental disorders.

AB - BACKGROUND, METHODS AND OBJECTIVES: Maternal autoantibodies to neuronal proteins may be one cause of neurodevelopmental disorders. This exploratory study used the Danish archived midgestational sera and their nationwide registers to search for antibodies to the N-methyl-D-aspartate receptor (NMDAR) and contactin-associated protein-like 2 (CASPR2) in maternal sera, and to relate them to subsequent psychiatric diagnoses in the woman or her child.RESULTS: In a sample of 192 women, there was no association between antibody status and subsequent psychosis in the mothers. However, NMDAR antibodies (n=4) or CASPR2 antibodies (n=1) were identified in 5/11 (45.5%) women whose children were given a diagnosis of mild or unspecified mental retardation or disorders of psychological and motor development (collectively abbreviated as mental retardation and/or disorders of psychological development (MR/DPD)) compared with 9/176 (5.1%) of the remaining mother (p<0.001). These findings were followed up in a specifically selected cohort, in which CASPR2 antibodies were detected in 7/171 (4.1%) mothers of MR/DPD progeny, compared with only 1/171 (0.6%) control mother (p=0.067). The combined sample showed a significantly higher frequency of CASPR2 antibodies in mothers of MD/DPD children (p=0.01). These autoantibodies were not increased in mothers of children with autistic spectrum disorder.CONCLUSIONS: These findings complement the known roles of CASPR2 in brain development, and warrant further epidemiological and experimental studies to clarify the role of CASPR2 and possibly other antibodies in neurodevelopmental disorders.

KW - Autoantibodies/immunology

KW - Brain/immunology

KW - Denmark

KW - Female

KW - Humans

KW - Infant, Newborn

KW - Intellectual Disability/diagnosis

KW - Membrane Proteins/immunology

KW - Mothers/psychology

KW - Nerve Tissue Proteins/immunology

KW - Pregnancy

KW - Receptors, N-Methyl-D-Aspartate

U2 - 10.1136/jnnp-2016-315251

DO - 10.1136/jnnp-2016-315251

M3 - Journal article

C2 - 28572274

VL - 88

SP - 718

EP - 721

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 9

ER -

ID: 243309487